A Randomized, Double-blind, Placebo-controlled, Forced Titration, Dose-ranging Study of AR08 in the Treatment of Vasomotor Symptoms (VMS) in Menopausal Females: A Proof-of-Concept Study
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2015
Price : $35 *
At a glance
- Drugs AR 08 (Primary)
- Indications Vasomotor symptoms
- Focus Proof of concept; Therapeutic Use
- Sponsors Arbor Pharmaceuticals
- 11 Feb 2015 Status changed from suspended to discontinued as reported by ClinicalTrials.gov record.
- 11 Jun 2014 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
- 10 Feb 2014 Status changed from not yet recruiting to recruiting according to ClinicalTrials.gov record.